FeedworthyAI
Science

BioPharm International articles

biopharminternational.com

BioPharm International articles

newsScience

Articles40

<![CDATA[Mechanical Robustness of 2R Glass Vials Across Fill/Finish Operations: Implications for Biopharma Manufacturing]]>

<![CDATA[Phase III Data from Durvalumab Combo Show Benefit in Early Liver Cancer ]]>

<![CDATA[How Does Oral Wegovy Outperform Foundayo in Weight Loss? ]]>

<![CDATA[Analytics that Matter: How LC and MALS Drive Biosimilar Success]]>

<![CDATA[Analytics that Matter- How LC and MALS Drive Biosimilar Success]]>

<![CDATA[Why Does the Future of Genetic Medicines Rely on LNP Targeting Strategies? Read What Experts Have to Say]]>

<![CDATA[Generare Raises €20 Million to Scale AI-Driven Molecular Discovery]]>

<![CDATA[Key Considerations for Drug Development Pipelines in Early Phase Clinical Trials]]>

<![CDATA[Teva Intensifies Biosimilar Competition with FDA Approval and Dual Filing Acceptance in US and Europe ]]>

<![CDATA[Being Specific About Being General: Vaccines Edition]]>

<![CDATA[FDA Approval of Kresladi Expands Gene Therapy in Pediatric Rare Diseases]]>

<![CDATA[Strategic Alliances in Bioprocessing and R&D: A Q&A with Dr. Manisha Desai of Bristol Myers Squibb]]>

<![CDATA[The BioPharm Brief: Talking Lifecycle Optimization, Strategic Investment, and Collaboration Shaping Growth Trajectory]]>

<![CDATA[FDA Approves High-Dose Spinraza to Advance SMA Treatment Strategy ]]>

<![CDATA[Examining the Architecture of Next-Gen Biotherapeutic Modalities]]>

<![CDATA[DCAT Week 2026: Where is the CDMO Market Heading?]]>

<![CDATA[Tozorakimab Phase III Data Establish IL-33 Pathway in COPD ]]>

<![CDATA[ Drug Digest: Examining the Growing Role of Partnerships in Modern Bioprocessing and Biopharma R&D with Bristol Myers Squibb's Dr. Manisha P. Desai]]>

<![CDATA[DCAT Week 2026: Insource or Partner with a CDMO?]]>

<![CDATA[Daiichi Sankyo Leverages AI to Strengthen ADC Clinical Strategy ]]>

<![CDATA[DCAT Week 2026: What is Driving the Pace of Injectable Capacity Investment?]]>

<![CDATA[UBT251 Phase II Data Intensify Triple-Agonist Competition in Diabetes]]>

<![CDATA[The BioPharm Brief: What’s the Big Deal About Multispecific T-Cell Engagers in Cancer and Autoimmune Diseases? ]]>

<![CDATA[Regulatory Momentum Builds for ADCs in Solid Tumor Oncology ]]>

<![CDATA[Market Shifts Powering the Growth of Sterile Injectable Manufacturing]]>

<![CDATA[Kali Therapeutics Licenses Tri-Specific T-Cell Engager to Sanofi ]]>

<![CDATA[AstraZeneca Builds End-to-End Cell Therapy Hub in China]]>

<![CDATA[Earendil Labs to Scale AI-Driven Biologics Platform with $787 Million Funding]]>

<![CDATA[The Ron Lanton Report: When Policy Becomes a Capital Event]]>

<![CDATA[The BioPharm Brief: Investments in Next-Gen Modalities Drive Oncology and Metabolic Therapy Development]]>

<![CDATA[Lilly Advances Triple Agonist Retatrutide in Type 2 Diabetes Treatment]]>

<![CDATA[Building Strategic Quality Partnerships for Sustainable Growth]]>

<![CDATA[Excalipoint Launches with $68.7 Million to Advance T-Cell Engager Platforms ]]>

<![CDATA[AstraZeneca Durvalumab Regimen Demonstrates Survival Benefit in Early Gastric Cancer]]>

<![CDATA[The BioPharm Brief: IL-23 Pathway Expansion Signals Next Wave of Immunology Lifecycle Development]]>

<![CDATA[How Conflict in the Middle East is Disrupting Bio/Pharma Drug Supplies: Report ]]>

<![CDATA[Sun Pharma's Tildrakizumab Advances into Psoriatic Arthritis as FDA Accepts sBLA]]>

<![CDATA[Shilpa Biologicals, mAbTree Program Targets Immune Pathway in Rare Blood Cancers ]]>

<![CDATA[Beyond the Safety Check: Why First-in-Human Trials Demand a New Approach in 2026]]>

<![CDATA[Propanc Advances PRP Toward Clinical Trials for Pancreatic Cancer ]]>